MIRNASH
Dead / Abandoned — Abandoned — failure to respond (as of 05 Feb 2026)
What this means for you
This application is over — abandoned 23 Jan 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97525742
- Mark type
- Stylized text
- Filed
- 29 Jul 2022
- Published for opposition
- 20 Jun 2023
- Abandoned
- 23 Jan 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- AptamiR Therapeutics, Inc., NAPLES, FL, US
- AptamiR Therapeutics, Inc., NAPLES, FL, US
Prosecution history
- 05 Feb 2026 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 05 Feb 2026 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 22 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Oct 2025 — NON-FINAL ACTION E-MAILED
- 22 Oct 2025 — SU - NON-FINAL ACTION - WRITTEN
- 01 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Sept 2025 — USE AMENDMENT FILED
- 01 Oct 2025 — SOU EXTENSION 4 GRANTED
- 14 Aug 2025 — SOU EXTENSION 4 FILED
- 16 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 16 Sept 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 16 Sept 2025 — NOTICE OF REVIVAL - E-MAILED
- 16 Sept 2025 — PETITION TO REVIVE-GRANTED
- 16 Sept 2025 — TEAS PETITION TO REVIVE RECEIVED